Israel vs Marshall Islands: Coverage of the human papillomavirus vaccine
Israel
51
in 2025
Marshall Islands
49
in 2025
Israel rank
62nd
Marshall Islands rank
64th
Coverage of the human papillomavirus vaccine over time
- Israel
- Marshall Islands
How they compare
Israel currently reports 51 against 49 in Marshall Islands, a difference of 2.
The two have swapped places 2 times across 10 shared years of data; in 2016 it was Israel ahead.
Israel ranks 62nd and Marshall Islands ranks 64th of 85 countries.
Israel has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Israel | Marshall Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 52.5 | 27.25 | 25.25 | Israel |
| 2020s | 54 | 49.5 | 4.5 | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher coverage of the human papillomavirus vaccine, Israel or Marshall Islands?
- Israel, at 51 against 49 in Marshall Islands as of 2025.
- What is the difference in coverage of the human papillomavirus vaccine between Israel and Marshall Islands?
- 2, with Israel ahead.
- How many years of comparable data are there for Israel and Marshall Islands?
- 10 years are reported by both, from 2016 to 2025.
- How do Israel and Marshall Islands rank globally for coverage of the human papillomavirus vaccine?
- Israel ranks 62nd and Marshall Islands ranks 64th of 85 countries.
- Where does this data come from?
- Our World in Data, published as Coverage of the human papillomavirus vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.